Biodefense Market Key Player Analysis By - Bavarian Nordic, Alnylam Pharmaceuticals, Inc., SIGA Technologies, Emergent BioSolutions Inc., Cleveland Bio Labs

The Biodefense market is expected to reach US$ 8,350.74 Mn in 2027 from US$ 4,108.24 Mn in 2019. The market is estimated to grow with a CAGR of 9.4% from 2020-2027.

Biodefense is a procedure that surgically removes the lining of uterus. It reduces menstrual flow, in some women. The major factor attributing to the growth of the market is the increase in the prevalence of gynecological disorders like cervical cancer, menorrhagia, abnormal vaginal bleeding, and POCD or polycystic ovarian disease in women.

Get Sample PDF of this Report @ https://www.theinsightpartners.com/sample/TIPRE00005377/?Source=openpr/10392

Competitive Landscape Biodefense Market:
Bavarian Nordic, Alnylam Pharmaceuticals, Inc., SIGA Technologies, Emergent BioSolutions Inc., Cleveland Bio Labs, Dynavax Technologies, Elusys Therapeutics, Inc., Soligenix, Altimmune, and Pluristem Therapeutics

The global biodefense market on the basis of product is segmented into anthrax, small pox, botulism, nuclear/radiation and others. In 2019, the anthrax segment accounted for the largest market share in the global biodefense market. The segment is expected to continue its dominance over the forecast period owing to increasing funding by the governments of other countries to develop and stockpile adequate vaccines against anthrax mainly through a variety of initiatives, such as BioShield Act, Biomedical Advanced Research and Development Authority (BARDA), and the Joint Program Executive Office for Chemical & Biological Defense. For instance, the US Department of Health and Human Services announced it would purchase an anthrax treatment for $25. Million from Elusys Therapeutics Inc., as a part of an emergency preparedness plan, in 2018.

The growth of the market is attributed to the some key driving factors such as presence of favorable government initiatives increase in the number of naturally occurring outbreaks, increasing threat of biological weapons and nuclear armed ICBM. However, low R&D funding by government in developing and underdeveloped economies are expected to restraint the growth of the market during the forecast years.

The biodefense market majorly consists of the players such as Bavarian Nordic, Alnylam Pharmaceuticals, Inc., SIGA Technologies, Emergent BioSolutions Inc., Cleveland Bio Labs, Dynavax Technologies, Elusys Therapeutics, Inc., Soligenix, Altimmune, and Pluristem Therapeutics. The companies are focused towards adoption of organic strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in November 2017, Dynavax Technologies Corporation has received FDA approval for HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older.

Global Biodefense Market – By Product
• Anthrax
• Small Pox
• Botulism
• Radiation/Nuclear
• Others

Biodefense Market – By Geography
• North America
o US
o Canada
o Mexico
• Europe
o France
o Germany
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o China
o India
o South Korea
o Japan
o Australia
o Rest of Asia Pacific
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Rest of Middle East and Africa
• South America
o Brazil
o Argentina
o Rest of South America

Company Profiles
• Bavarian Nordic
• Alnylam Pharmaceuticals, Inc.
• SIGA Technologies
• Emergent BioSolutions Inc.
• Cleveland Bio Labs
• Dynavax Technologies
• Elusys Therapeutics, Inc.
• Soligenix
• Altimmune
• Pluristem Therapeutics

WHAT'S INCLUDED:
• Market Dynamics
• Competitive Analysis
• Market Trends And Market Outlook
• Market Share And Market Size
• Opportunities And Customer Analysis
• Product Pricing Research

Interested in Purchasing this Report? Click here @ https://www.theinsightpartners.com/buy/TIPRE00005377/?Source=openpr/10392

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Key Highlights of the Table of Contents:
1. Biodefense Market Study Coverage: It includes key market segments, key manufacturers covered, the scope of products offered in the years considered, global Biodefense Market and study objectives. Additionally, it touches the segmentation study provided in the report on the basis of the type of product and applications.
2. Biodefense Market Executive summary: This section emphasizes the key studies, market growth rate, competitive landscape, market drivers, trends, and issues in addition to the macroscopic indicators.
3. Biodefense Market Production by Region: The report delivers data related to import and export, revenue, production, and key players of all regional markets studied are covered in this section.
4. Biodefense Market Profile of Manufacturers: Analysis of each market player profiled is detailed in this section. This segment also provides SWOT analysis, products, production, value, capacity, and other vital factors of the individual player.

Call: +1-646-491-9876
Email: sales@theinsightpartners.com

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.